MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Ingevity Stock

Ingevity Corporation

NGVTNYSEMarkt
US$69.82
-1.0% today

Company data

Sector
Basic Materials
Industry
Chemicals - Specialty
Country
United States
CEO
David H. Li
Employees
1,500
Market cap
$2.4 B
IPO
03/05/2016

Ingevity Corporation is a global provider specializing in the production and distribution of advanced chemical solutions and activated carbon products. Headquartered in North Charleston, USA, the company was founded in 1964. Its operations span across North America, the Asia Pacific region, Europe, the Middle East,…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

Ingevity stock: price history

16/10/25+25.8 %16/10/26

1D

-1.0%

1W

+0.1%

1M

+2.3%

6M

-7.2%

YTD

+18.0%

1Y

+25.8%

2Y

+96.6%

5Y

-10.4%

10Y

+63.9%

Next earnings date

Next earnings date

04/11/2026 (in 18 days)

Volatility around earnings

~55% stronger price swings than usual

Ask the agents about Ingevity

Analyst assessment of Ingevity

PRICE TARGET LOW

US$56.00

CONSENSUS

US$71.50

MEDIAN

US$73.50

PRICE TARGET HIGH

US$83.00

0

STRONG BUY

10

BUY

3

HOLD

0

SELL

0

STRONG SELL

13

TOTAL · Buy

As of: 27/02/2026

ANALYST FIRMRATINGACTIONDATE
Wells FargoEqual Weightmaintain27/02/2026
Wells FargoEqual Weightmaintain29/01/2026
Wells FargoEqual Weightmaintain19/12/2025
BMO CapitalOutperformmaintain10/12/2025
Wells FargoEqual Weightmaintain12/11/2025
BMO CapitalOutperformmaintain05/09/2025 (older than 12 months)
BMO CapitalOutperformmaintain07/08/2025 (older than 12 months)
Wells FargoEqual Weightmaintain14/07/2025 (older than 12 months)

Ingevity stock metrics

P/E

45.34

P/B

52.1

EV/EBITDA

18.24

RETURN ON EQUITY

75.3%

NET MARGIN

11.2%

DEBT/EQUITY

26.36

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

99.0%

FLOAT SHARES

34,042,737

AVG. DAILY VOLUME (30D)

266,813

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Segal Francis David

DirectorGrant33571.09Spontaneous02/10/2026

WILLIS J KEVIN

DirectorGrant40571.09Spontaneous02/10/2026

Li David H

OfficerSale5,00075.73Pre-planned18/08/2026

Li David H

OfficerSale9274.71Pre-planned18/08/2026

Li David H

OfficerSale5,00075.83Pre-planned18/08/2026
Page 1 / 6

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
WEDGE CAPITAL MANAGEMENT L L P/NC65,972+1,13230/09/2026
SALEM INVESTMENT COUNSELORS INC44,722+030/09/2026
MOODY NATIONAL BANK TRUST DIVISION41,411-5430/09/2026
DAVENPORT & Co LLC26,177-64930/09/2026
Fruth Investment Management16,557+030/09/2026
Page 1 / 3

Comparable stocks

Frequently asked questions about Ingevity stock

What does Ingevity do?

Ingevity Corporation is a company in the Basic Materials sector, Chemicals - Specialty industry, headquartered in United States.

The CEO is David H. Li, the company employs around 1,500 people.

The IPO was on 03/05/2016; the stock trades on NYSE under the ticker NGVT.

What do analysts say about Ingevity stock?

13 analysts rate the stock, the consensus is Buy (as of 27/02/2026).

The average price target is US$71.50, ranging from US$56.00 to US$83.00, with a median of US$73.50.

This is an external assessment, not a statement by Market Jury.

When does Ingevity report next?

The next earnings date is 04/11/2026.

Around past earnings, price swings were roughly 55% stronger than usual.

Does Ingevity pay a dividend?

No, Ingevity currently does not pay a dividend.

Which stocks are comparable to Ingevity?

Comparable stocks include Ecolab, Sherwin-Williams Company, Air Products and Chemicals, PPG Industries, International Flavors & Fragrances, Albemarle, NewMarket and Axalta Coating Systems.

How can I get Ingevity stock analyzed?

Clicking "Analyze stock" lets five strategies assess Ingevity against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.